Doximity increases by 69% in debut after the IPO values ​​the company at $ 4.6 billion

Doximity, the company that calls itself LinkedIn for doctors, jumped by 69% in his escort market debut on Thursday after raising nearly $ 500 million in its IPO.

Doximity sold 19 million shares for $ 26 per piece on Wednesday night, above expected range of $ 20 to $ 23 and an existing investor sold another 4.3 million. The offer valued the company at $ 4.6 billion. The escort, trading under the “DOCS” symbol, climbed at $ 44.13 shortly after opening.

Founded in 2010, Doximity grew rapidly in in recent years becoming the main app that doctors use to stay connected with one another, sharing the latest research and updates on new drugs. With 1.8 million medical professionals in the United States on the site, including over 80% of doctors, Doximity boosted revenue by enabling pharmaceutical companies to promote drugs and treatments and by giving medical recruiters a central role place to find prospects.

Revenue increased by 77% in the latest tax year to $ 206.9 million, according to the company prospectus. Because Doximity spends practically nothing money on advertising, operating the costs are lower than the maximum venture-backed software companies. This allowed Doximity to increase net income from 69% to $ 50.2 million in the tax year that is over in March.

The intersection of health and technology took center stage last year as the coronavirus pandemic has forced patients to get comfortable with remote visits and strained resources of health systems in all over the country. Investors have seized the opportunity to profit from economic changes.

In August, telehealth the supplier Teladoc has acquired Livongo, a specialist in remote coaching for chronic conditions, creating at the time a $ 37 billion company. Telemedicine rival Amwell is gone public in September. Teladoc and Amwell both traded lower in in recent months with the collapse of Covid-19 cases and future growth rates for businesses have come in discussion.

Meantime, telehealth company MDLive was acquired by Cigna in February for an undisclosed amount and two venture- sustained health -tech companies, Grand Rounds and Doctor on Question, purr in March, creating a multibillionaire-dollar business.

For Doximity, telehealth it’s a new business. The company has been offering a free service since 2016 that allows doctors a call patients using their work number on a mobile Phone. Doximity moved the dialer service at his main app in 2019.

In May 2020, the company added video, which he described as his “first telemedicine offering. “Doximity launched a paid business version, although it stated that the video service would be free until January 2021. In its prospectus, Doximity claimed to have signed subscription agreements with over 150 hospitals like of the end of March.

Jeff Tangney, co-founder and CEO of Doximity, said in an interview that although over 80% of doctors are on the network, the company has at least a decade of “what we consider high growth”forward why of the value it can bring to healthcare system. For example, postponement system can get much stronger, in so that doctors know exactly where in the country to send patients who have rare cancer.

he also said Doximity has a lot of expansion opportunities in telehealth given the size of its user base for its main product.

“Telemedicine is at 2% of rev today and it’s such a green field, ”Tangney said, after playing the opening bell on the New York Stock Exchange. “We weren’t aggressive on still the price. “

Doximity is overall growth is less dependent on telehealth compared to other suppliers in the market because its primary sources of income is not related to the doctor-patient communications. However, the company acknowledges that at the end of the pandemic, its business could be hurt. Doximity benefited like more the doctors’ offices brought theirs budget of marketing online, and some of that the expense could come back back to physical advertising.

“The circumstances that accelerated the growth of our business resulting from the effects of the COVID-19 pandemic may not continue in the future”said Doximity.” If these customers reassign a significant portion of their budget back for in- marketing person, this could cause our growth for decline in future periods. “

Tangney, who previously co-founded digital Epocrates health site, is the largest stakeholder of the company, with shares valued at around $ 1.3 billion, based on the IPO price. Emergence Capital is the largest outside investor, with a stake of $ 627 million, followed by InterWest Partners and Morgenthaler.

The IPO marks Doximity’s first funding since 2014, when the company raised $ 54 million with a valuation of $ 355 million, according to PitchBook.

As a part of the offer, Doximity reserved 15% of the shares for doctors in the network. Assuming doctors are at their best out their stake, they bought about $ 91 million worth of Doximity stock.

Tangney said over 10,000 doctors attended in the offer, the purchase up to $ 24,000 worth of shares. As a group, possess more any single stock new investor, he said.

CLOCK: Doximity CEO on doctor social network going public

Read More About Business News around the World here!

Source

Leave a Reply